• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

Recent Advances in the Study of 2-Acetoxy-4'-phenoxybenzophenone (CAS: 890098-30-3) in Chemical Biology and Pharmaceutical Research

The compound 2-Acetoxy-4'-phenoxybenzophenone (CAS: 890098-30-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique benzophenone core structure, has shown promising potential in various applications, including drug development, photochemical studies, and material science. Recent studies have focused on elucidating its synthesis pathways, biological activities, and potential therapeutic applications, making it a subject of intense scientific inquiry.

One of the key areas of interest is the compound's role as a photoactive moiety in photopharmacology. Researchers have explored its ability to undergo photochemical transformations upon exposure to specific wavelengths of light, which can be harnessed for controlled drug release or targeted therapy. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 2-Acetoxy-4'-phenoxybenzophenone could be used to develop light-activated prodrugs, offering a novel approach to minimizing off-target effects in cancer treatment.

In addition to its photochemical properties, the compound has been investigated for its potential as an intermediate in the synthesis of more complex pharmaceutical agents. A recent patent application highlighted its utility in the production of kinase inhibitors, which are crucial for treating various cancers and inflammatory diseases. The patent detailed a scalable synthetic route for 2-Acetoxy-4'-phenoxybenzophenone, emphasizing its cost-effectiveness and high yield, which could facilitate its broader adoption in industrial pharmaceutical production.

Further studies have delved into the compound's biological activities, particularly its interactions with cellular targets. In vitro assays have revealed that 2-Acetoxy-4'-phenoxybenzophenone exhibits moderate inhibitory effects on certain enzymes involved in inflammatory pathways. These findings, published in a 2022 issue of Bioorganic & Medicinal Chemistry Letters, suggest that the compound could serve as a lead structure for developing new anti-inflammatory agents, though further optimization is needed to enhance its potency and selectivity.

Despite these promising developments, challenges remain in fully understanding the compound's pharmacokinetics and toxicity profile. Preliminary toxicological studies indicate that 2-Acetoxy-4'-phenoxybenzophenone may have limited systemic toxicity, but comprehensive in vivo studies are still required to confirm its safety for therapeutic use. Researchers are also exploring modifications to its chemical structure to improve its bioavailability and reduce potential side effects.

In conclusion, 2-Acetoxy-4'-phenoxybenzophenone (CAS: 890098-30-3) represents a versatile and promising compound in the realm of chemical biology and pharmaceutical research. Its unique properties and diverse applications underscore its potential as a valuable tool for drug discovery and development. Continued research efforts will be essential to unlock its full therapeutic potential and address the remaining challenges in its clinical translation.

• 890099-06-6(2-ACETOXY-2',5'-METHYLBENZOPHENONE)
• 42059-48-3(Ethanone, 1-[4-(acetyloxy)-2-hydroxyphenyl]-)
• 7250-94-4(2-Acetoxyacetophenone)
• 890098-40-5(2-Acetoxy-4'-t-butylbenzophenone)
• 37135-48-1(2-Acetoxy-4'-ethylbenzophenone)
• 890099-09-9(2-ACETOXY-2',6'-METHYLBENZOPHENONE)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)